These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12374233)

  • 1. Elevated arterial compliance in patients with cirrhosis is not related to arterial endothelin-1.
    Møller S; Gülberg V; Becker U; Gerbes AL; Henriksen JH
    Scand J Gastroenterol; 2002 Sep; 37(9):1064-9. PubMed ID: 12374233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma endothelin-1 concentrations in children with cirrhosis and their relationship to renal function and the severity of portal hypertension.
    Bakr AM; Abdalla AF; El-Marsafawy H; Abu-Hashem I; El-Regal ME; Amer T; Abdel-Khalik MK; Mostafa H; A-Kader HH
    J Pediatr Gastroenterol Nutr; 2002 Aug; 35(2):149-53. PubMed ID: 12187289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems.
    Henriksen JH; Møller S; Schifter S; Abrahamsen J; Becker U
    Gut; 2001 Jul; 49(1):112-8. PubMed ID: 11413119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial.
    Tripathi D; Therapondos G; Ferguson JW; Newby DE; Webb DJ; Hayes PC
    Gut; 2006 Sep; 55(9):1290-5. PubMed ID: 16434427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
    Spahr L; Giostra E; Frossard JL; Morard I; Mentha G; Hadengue A
    Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Q-T interval (QT(C)) in patients with cirrhosis: relation to vasoactive peptides and heart rate.
    Henriksen JH; Gülberg V; Fuglsang S; Schifter S; Bendtsen F; Gerbes AL; Møller S
    Scand J Clin Lab Invest; 2007; 67(6):643-53. PubMed ID: 17852825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee WC; Lee FY; Chang FY; Lee SD
    Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of two different dosages of octreotide on portal pressure and hepatic hemodynamics in cirrhotic portal hypertensive patients after portal-azygous devascularization and splenectomy].
    Lu SC; Meng FK; Ding HG; Zhang JG; Ding L; Wang SZ
    Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):290-3. PubMed ID: 17637266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.
    Cavasin MA; Semus H; Pitts K; Peng Y; Sandoval J; Chapo J; Plato CF
    Can J Physiol Pharmacol; 2010 Jun; 88(6):636-43. PubMed ID: 20628429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased arterial compliance in decompensated cirrhosis.
    Henriksen JH; Møller S; Schifter S; Bendtsen F
    J Hepatol; 1999 Oct; 31(4):712-8. PubMed ID: 10551396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1 and endothelin-3 in cirrhosis: relations to systemic and splanchnic haemodynamics.
    Møller S; Gülberg V; Henriksen JH; Gerbes AL
    J Hepatol; 1995 Aug; 23(2):135-44. PubMed ID: 7499784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of beta-adrenergic blockade on elevated arterial compliance and low systemic vascular resistance in cirrhosis.
    Møller S; Bendtsen F; Henriksen JH
    Scand J Gastroenterol; 2001 Jun; 36(6):653-7. PubMed ID: 11424326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial hypertension in cirrhosis: arterial compliance, volume distribution, and central haemodynamics.
    Henriksen JH; Fuglsang S; Bendtsen F; Møller S
    Gut; 2006 Mar; 55(3):380-7. PubMed ID: 16474108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of somatostatin versus octreotide on portal haemodynamics in patients with cirrhosis and portal hypertension.
    Yang JF; Wu XJ; Li JS; Cao JM; Han JM
    Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):53-7. PubMed ID: 15647641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased arterial compliance in cirrhosis is related to decreased arterial C-type natriuretic peptide, but not to atrial natriuretic peptide.
    Henriksen JH; Gülberg V; Gerbes AL; Bendtsen F; Møller S
    Scand J Gastroenterol; 2003 May; 38(5):559-64. PubMed ID: 12795471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial compliance in patients with cirrhosis: stroke volume-pulse pressure ratio as simplified index.
    Henriksen JH; Fuglsang S; Bendtsen F; Christensen E; Møller S
    Am J Physiol Gastrointest Liver Physiol; 2001 Apr; 280(4):G584-94. PubMed ID: 11254484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 48-hour hemodynamic effects of octreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension: double-blind, placebo-controlled study.
    Ludwig D; Schädel S; Brüning A; Schiefer B; Stange EF
    Dig Dis Sci; 2000 May; 45(5):1019-27. PubMed ID: 10795771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide in liver cirrhosis: a salvage for variceal bleeding can be a gunshot for kidneys.
    Güney Duman D; Tüney D; Bilsel S; Benli F; Karan S; Avsar E; Ozdogan O; Tözün N
    Liver Int; 2005 Jun; 25(3):527-35. PubMed ID: 15910489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison.
    Baik SK; Jeong PH; Ji SW; Yoo BS; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ; Lee SS
    Am J Gastroenterol; 2005 Mar; 100(3):631-5. PubMed ID: 15743362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.
    Wang JJ; Gao GW; Gao RZ; Liu CA; Ding X; Yao ZX
    World J Gastroenterol; 2004 Mar; 10(5):689-93. PubMed ID: 14991939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.